Viva Biotech Recognized for Excellence in Drug Discovery
Viva Biotech stands at the forefront of innovation in the pharmaceutical industry, especially highlighted by its recent recognition from Frost & Sullivan for its pioneering work in AI-driven drug discovery platforms. The company is celebrated for accelerating timelines, cutting costs, and amplifying therapeutic innovations within the global pharmaceutical R&D landscape.
Achievements and Impact
In September 2025, Frost & Sullivan honored Viva Biotech with the prestigious 2025 APAC Technology Innovation Leadership award in the Integrated Intelligent Drug Discovery sector. This accolade recognizes the company's significant contributions to improving efficiency in preclinical research and development. It emphasizes how Viva Biotech skillfully merges artificial intelligence with lab-driven validation, which is reshaping the future of drug discovery.
Efficiency in Pharmaceutical Research
Viva Biotech has demonstrated excellence in strategy effectiveness and execution, skillfully aligning advanced technologies with evolving client demands. According to Priyanka Jain, a senior research analyst at Frost & Sullivan, the company has established one of the most versatile discovery platforms in the industry. From small molecules and antibodies to novel therapies like PROTACs and molecular glues, Viva Biotech's AI-driven approach greatly reduces development timelines and costs for its global clientele.
Innovative Platforms and Future Directions
At the heart of Viva Biotech’s operations is its cutting-edge Artificial Intelligence-Driven Drug Discovery (AIDD) framework, which includes proprietary tools such as V-Scepter, V-Orb, and V-Mantle. These modules not only tackle persistent drug design issues but also integrate predictive modeling with practical laboratory experimentation, enabling quick validation and iterative development of drug candidates. Dr. Derek Ren, CEO of Viva Biotech (Shanghai) Ltd., expressed pride in receiving this award and highlighted the alignment of their vision with technological advancements in drug discovery.
Commitment to Client Experience
Viva Biotech's commitment to enhancing client experience solidifies its strong global position. By offering adaptable collaboration models and milestone-based agreements, the company ensures complete ownership of intellectual property for its partners. This strategy not only diminishes project risks but also empowers clients to confidently explore new therapeutic modalities with scientific rigor and agility.
Market Recognition and Benchmarking
Frost & Sullivan’s recognition is a testament to Viva Biotech’s success in establishing benchmarks for technological innovation and strategic execution. The company’s AI-powered methodologies, backed by top-notch expertise in structural biology and preclinical experimentation, are shaping the future of integrated intelligent drug discovery.
Every year, Frost & Sullivan bestows the Technology Innovation Leadership award to firms that excel in strategic development and execution, ultimately leading to significant enhancements in market share and customer satisfaction. This distinction highlights the organizations that redefine industry standards through innovative practices.
About Viva Biotech
Viva Biotech, established in 2008, provides comprehensive services encompassing early-stage Structure-Based Drug R&D to commercial manufacturing tailored for global biopharmaceutical innovators. The company offers an array of expertise that integrates advanced technology, skilled personnel, and state-of-the-art equipment for drug discovery efforts across various therapeutic strategies and modalities.
Frequently Asked Questions
What recognition did Viva Biotech receive from Frost & Sullivan?
Viva Biotech was awarded the 2025 APAC Technology Innovation Leadership award in the Integrated Intelligent Drug Discovery sector.
How does Viva Biotech utilize AI in its drug discovery process?
The company employs AI technologies to accelerate the drug discovery timeline and reduce associated costs while improving overall therapeutic innovation.
What are some tools used by Viva Biotech in its AIDD platform?
Viva Biotech's AIDD platform includes proprietary tools such as V-Scepter, V-Orb, and V-Mantle, which enhance drug design capabilities.
How does Viva Biotech ensure client satisfaction?
Viva Biotech enhances client satisfaction through flexible collaboration models and milestone agreements that grant complete ownership of intellectual property.
When was Viva Biotech founded?
Viva Biotech was founded in 2008 and has since evolved to cater to the needs of global biopharmaceutical innovators.
